Randomized Phase II Study of Cetuximab and Bevacizumab in Combination with Two Regimens of Paclitaxel and Carboplatin in Chemonaive Patients with Stage IIIB/IV Non–Small-Cell Lung... by Bonomi, Philip D., Mace, Joseph, Mandanas, Romeo A., Min, Myo, Olsen, Mark, Youssoufian, Hagop, Katz, Terry L., Sheth, Grishma, Lee, Hyun Jung

Get full text

A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete... by Rifkin, Robert M., Greenspan, Andrew, Schwerkoske, John F., Mandanas, Romeo A., Stephenson, Joe J., Kannarkat, George T., Zhan, Feng, Boehm, Kristi A., Asmar, Lina, Beveridge, Roy

Get full text

Impaired gastric slow wave rhythmicity in patients after bone marrow or stem cell transplant by XIAOHONG XU, MANDANAS, Romeo A, XUEMEI LIN, CHEN, J. D. Z

Get full text

A Randomized, Multicenter, Open-Label Comparison of the Antiemetic Efficacy of Dolasetron Versus Ondansetron for the Prevention of Nausea and Vomiting During High-Dose Myeloablativ... by Mandanas, Romeo A., Beveridge, Roy, Rifkin, Robert M., Wallace, Hugh, Greenspan, Andrew, Asmar, Lina

Get full text

Home Administration of Romiplostim by Patients with Chronic Immune Thrombocytopenia (ITP) by Lyons, Roger M, Boccia, Ralph V., Macik, Gail, Mandanas, Romeo A., Wang, Xuena, Lizambri, Richard, Berger, Dietmar

Get full text

Results of a Phase II Open-Label Trial of Bortezomib in Patients with Multiple Myeloma Who Have Undergone High-Dose Melphalan Therapy Followed by Autologous Peripheral Blood Stem C... by Rifkin, Robert M., Spitzer, Gary, Greenspan, Andrew, Schwerkoske, John F., Mandanas, Romeo A., Stephenson, Joe, Kannarkat, George T., Zhan, Feng, Asmar, Lina, Beveridge, Roy

Get full text

Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells by MANDANAS, R. A, LEIBOWITZ, D. S, KAMRAN GHAREHBAGHI, TAUCHI, T, BURGESS, G. S, MIYAZAWA, K, JAYARAM, H. N, BOSWELL, H. S

Get full text

Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care by Kuter, David J., Mathias, Susan D., Rummel, Mathias, Mandanas, Romeo, Giagounidis, Aristoteles A., Wang, Xuena, Deuson, Robert R.

Get full text

Use of Rituximab in a Study Comparing the Thrombopoietin Mimetic Romiplostim with Standard of Care (SOC) in Patients with Immune Thrombocytopenia (ITP) by Wasser, Jeffrey, Boccia, Ralph Vincent V., Lyons, Roger M., Mandanas, Romeo, Pabinger, Ingrid, IV, Marc Michel, Viallard, Jean-François, Wang, Xuena, Lizambri, Richard

Get full text

Patient Quality of Life (QOL) In Nonsplenectomized Immune Thrombocytopenia (ITP) Patients Receiving Romiplostim or Medical Standard of Care (SOC) by Rummel, Mathias J., Kuter, David J., Mandanas, Romeo, Giagounidis, Aristoteles, Wang, Xuena, Mathias, Susan D., Deuson, Robert

Get full text

Pegfilgrastim Appears Equivalent to Daily Dosing of Filgrastim to Treat Neutropenia After Autologous Peripheral Blood Stem Cell Transplantation in Patients With Non-Hodgkin Lymphom... by Rifkin, Robert, Spitzer, Gary, Orloff, Gregory, Mandanas, Romeo, McGaughey, Dean, Zhan, Feng, Boehm, Kristi A, Asmar, Lina, Beveridge, Roy

Get full text

Results of a Randomized Phase II Trial of Pegfilgrastim Versus Filgrastim To Treat Neutropenia Post-Autologous Peripheral Blood Stem Cell Transplant (PBSCT) in Patients with Non-Ho... by Rifkin, Robert, Beveridge, Roy, Spitzer, Gary, Orloff, Gregory, Mandanas, Romeo, McGaughey, Dean, Brunvand, Mark, Zhan, Feng, Boehm, Kristi A., Asmar, Lina

Get full text